文献速递慢性肾脏病肾血管病与高血压血液净化与透析

墨西哥成人血压与肾功能及肾脏死亡的关系

Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults.
PubMed 文献 · Am J Kidney Dis · 2026-08-13

这项前瞻性队列研究纳入133,470名墨西哥城成人,随访约20年,发现收缩压每降低20 mmHg,肾衰竭死亡风险降低24%(HR 0.76,95%CI 0.69-0.84);高血压归因于9%的肾衰竭死亡。在再评估亚组中,基线收缩压每降低20 mmHg与CKD和蛋白尿的 odds 均降低24%相关。

要点

  • 收缩压每降低20 mmHg,肾衰竭死亡风险降低24%(HR 0.76)。
  • 高血压可归因于9%的肾衰竭死亡。
  • 基线收缩压每降低20 mmHg,CKD和蛋白尿风险均降低24%(OR 0.76)。

核心结论

  • 在墨西哥成人中, elevated BP 是肾衰竭死亡、CKD和蛋白尿的主要可干预危险因素。

研究设计与样本

  • 前瞻性队列研究,纳入133,470名35至<85岁、无CKD或其他慢性病(除糖尿病外)的墨西哥城成人,1998-2004年招募,随访≥5年;随机亚组9,198人于2015-2019年再评估。

主要发现

  • 收缩压与肾衰竭死亡呈连续对数线性关联,年龄40-84岁者收缩压每低20 mmHg的肾衰竭死亡HR为0.76(95%CI 0.69-0.84)。
  • 无糖尿病者HR为0.54(95%CI 0.45-0.69),有糖尿病者HR为0.90(95%CI 0.80-1.01),但绝对超额风险相似。
  • 高血压占肾衰竭死亡的9%。
  • 再评估亚组中6%发生CKD,25%有蛋白尿;基线收缩压每低20 mmHg与CKD(OR 0.76,95%CI 0.68-0.85)和蛋白尿(OR 0.76,95%CI 0.68-0.84)的 odds 降低相关。
  • 舒张压结果与收缩压相似。

临床怎么用

  • 在墨西哥成人中,降低血压可能减少肾衰竭死亡、CKD和蛋白尿的发生。

局限性

  • 基线无尿样,无法评估肾功能随时间的变化趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) is a major cause of death in Mexico, and blood pressure (BP) may be an important contributor. This study investigated the associations of BP with CKD, albuminuria, and death from kidney failure. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 133,470 adults aged ≥35 to <85 years without CKD or other chronic disease (except diabetes), recruited from 2 districts of Mexico City between 1998 and 2004, and who had survived ≥5 years after recruitment. A random subset of 9,198 underwent additional evaluation from 2015 to 2019. EXPOSURE: Systolic BP (SBP), diastolic BP (DBP) and hypertension (defined as participant report, taking BP-lowering medication, and/or BP ≥ 140/90 mm Hg). OUTCOME: Kidney failure mortality during follow-up, and CKD (self-report and/or estimated glomerular filtration rate < 60 mL/min/1.73 m2) and albuminuria at the time of repeat clinical evaluation. ANALYTICAL APPROACH: Multivariable Cox regression for the association of BP with kidney failure mortality and multivariable logistic regression for the association of baseline BP with CKD and albuminuria at the time of re-evaluation. RESULTS: Among all participants, SBP showed a continuous log-linear association with kidney failure mortality; each 20 mm Hg lower SBP was associated with a 24% lower risk at ages 40-84 years (kidney failure death HR, 0.76 [95% CI, 0.69-0.84]). The association was stronger among those without diabetes (HR, 0.54 [95% CI, 0.45-0.69]) than with diabetes (HR, 0.90 [95% CI, 0.80-1.01]), but the absolute excess risk associated with higher BP was similar in these subgroups. Hypertension accounted for 9% of kidney failure deaths. Among those re-evaluated, 6% had developed CKD, and 25% had albuminuria. A 20 mm Hg lower baseline SBP was associated with 24% lower odds of both CKD (OR, 0.76 [95% CI, 0.68-0.85]) and albuminuria (OR, 0.76 [95% CI, 0.68-0.84]) at the time of re-evaluation. The results were similar for DBP. LIMITATIONS: Baseline urine samples were unavailable, and kidney function trends over time could not be assessed. CONCLUSIONS: This large prospective study in Mexican adults highlights elevated BP as a major modifiable risk factor for kidney failure mortality, CKD, and albuminuria. PLAIN-LANGUAGE SUMMARY: Kidney disease is a major cause of death in Mexico, and high blood pressure may play an important role. The Mexico City Prospective Study followed approximately 150,000 Mexican adults aged 35 years or older for approximately 20 years, tracking causes of death over time. These analyses found that lower blood pressure was linked to a lower risk of dying from kidney failure. For every 20 mm Hg lower systolic blood pressure, the risk of dying from kidney failure was lower by approximately one quarter. High blood pressure accounted for 9% of all deaths from kidney failure. Lower blood pressure also was associated with better kidney function-as measured by blood tests, participant questionnaires, and urine protein levels-some years later. These analyses suggest that reducing high blood pressure is likely to prevent kidney disease and deaths related to kidney disease in Mexico.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Zhu D, Kuri-Morales P, Wade R, et al. Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults. Am J Kidney Dis. 2026. PMID: 42595039. doi:10.1053/j.ajkd.2026.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。